FDA approves Mesoblast's Ryoncil, the first U.S. MSC therapy, for children with steroid-refractory acute graft-versus-host disease. In a Phase 3 trial, 70% of SR-aGvHD patients responded to ...

Bank Indonesia Governor Perry Warjiyo vowed to cooperate with a corruption probe of the central bank, which was raided earlier this week by the country’s anti-graft agency. Warjiyo said the ...

Dec 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Mesoblast's (MSB.AX), opens new tab cell therapy for treating a type of complication that occurs after a stem cell or ...